Syncom Healthcare submits statement on investor complaints

15 Apr 2017 Evaluate

Pursuant to the provision of Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, Syncom Healthcare has submitted a Statement on Investor Complaints for the quarter ended 31st March 2017.

The above information is a part of company’s filings submitted to BSE.

Theta Pharmaceutical Share Price

4.12 0.00 (0.00%)
28-Jun-2021 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×